Regenerative Medicine Today welcomes Dr. Juliana Blum Dr. Blum is the Co-Founder and Executive Vice President Corporate Development of Humacyte, a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at a commercial scale. Dr. Blum discusses her work at Humacyte, focusing on the development and manufacture of bioengineered human tissues. This podcast was recorded in conjunction with the Journal of Immunology and Regenerative Medicine.
*Humacyte’s products are not yet approved by the U.S. Food and Drug Administration and are currently in clinical evaluation.
For more information about Dr. Blum and Humacyte, please click here.
Host John Murphy.
For more information about the McGowan Institute for Regenerative Medicine, visit: